RxDoctor Payments Data

Patrick Fox, MD

Family Medicine · Mena, ARNPI 1003963208

Payments from drug & device makers

$830in general payments, 2019–2025

Across 53 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$297
  • GSK$144
  • Pfizer$122
  • Abbott$45
  • AstraZeneca$35
  • Genentech USA, Inc.$34
  • plus $154 from 9 others

What the payments were for

  • Food & beverage$830100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$830 in reported general payments places this provider in the 55th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$33,650
Medicare patients
336
Services billed
2,456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban143$112,665
Trelegy ElliptaFluticasone/Umeclidin/Vilanter125$94,622
OzempicSemaglutide66$85,258
BiktarvyBictegrav/Emtricit/Tenofov Ala12$50,204
FarxigaDapagliflozin Propanediol53$38,790
JardianceEmpagliflozin57$36,614
JanuviaSitagliptin Phosphate48$35,877
MounjaroTirzepatide30$27,691
XareltoRivaroxaban27$22,001
LinzessLinaclotide34$21,459
JanumetSitagliptin Phos/Metformin Hcl20$18,950
Bevespi AerosphereGlycopyrrolate/Formoterol Fum27$11,610
Breo ElliptaFluticasone/Vilanterol27$11,554
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$10,777
Aimovig AutoinjectorErenumab-Aooe13$9,209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$122$120,794160 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$144$114,566170 claims
AstraZenecaFarxiga, Bevespi Aerosphere, Brilinta$35$55,83494 claims
MerckJanuvia, Janumet$12$54,82868 claims
GileadBiktarvy$32$50,20412 claims
Lilly USA, LLCMounjaro$13$27,69130 claims
AbbVieLinzess$297$21,45934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Mena

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →